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A 30‐year‐old Asian Indian woman with history of breast cancer has presented with blackish discoloration above the site of intravenous access on right forearm \[Fig. [1](#ccr31102-fig-0001){ref-type="fig"}A\] after 1 week of infusion of docetaxel through a peripheral venous catheter. She was recently started on palliative single agent chemotherapy with docetaxel 75 mg/m^2^ for metastatic disease and did not have a central venous port. We diagnosed the rash as serpentine supravenous hyperpigmentation secondary to docetaxel. In addition, she was also noted to have other dermatologic manifestations of docetaxel, namely blackish discoloration of the palms \[Fig. [1](#ccr31102-fig-0001){ref-type="fig"}C\], horizontal banding and pigmentation of nails \[Fig. [1](#ccr31102-fig-0001){ref-type="fig"}B\], and alopecia [1](#ccr31102-bib-0001){ref-type="ref"}, [2](#ccr31102-bib-0002){ref-type="ref"}, [3](#ccr31102-bib-0003){ref-type="ref"}, [4](#ccr31102-bib-0004){ref-type="ref"}.

![(A) Hyperpigmentation along the superficial veins of the forearm. (B) Horizontal banding and pigmentation of nails. (C) Blackish discoloration of the palms.](CCR3-5-1546-g001){#ccr31102-fig-0001}
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